Favorable outcomes with reduced steroid use in juvenile dermatomyositis

BACKGROUND: High-intensity glucocorticoid regimens are commonly used to induce and maintain remission in Juvenile Dermatomyositis but are associated with several adverse side-effects. Evidence-based treatment guidelines from North American and European pediatric rheumatology research societies both...

Descripción completa

Detalles Bibliográficos
Autores principales: Orandi, Amir B., Fotis, Lampros, Lai, Jamie, Morris, Hallie, White, Andrew J., French, Anthony R., Baszis, Kevin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369654/
https://www.ncbi.nlm.nih.gov/pubmed/34404425
http://dx.doi.org/10.1186/s12969-021-00615-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369654/
https://www.ncbi.nlm.nih.gov/pubmed/34404425
http://dx.doi.org/10.1186/s12969-021-00615-0

Ejemplares similares